Skip to main navigation Skip to search Skip to main content

Tenofovir is superior to entecavir on recurrence in hepatitis B virus-related hepatocellular carcinoma after curative resection

  • Ming-Chao Tsai
  • , Chih-Chi Wang
  • , Wei-Chen Lee
  • , Yueh-Wei Liu
  • , Chih-Che Lin
  • , Tsung-Hui Hu

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
Pages (from-to)163-163
JournalJournal of Gastroenterology and Hepatology
Volume36
StatePublished - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • entecavir (ETV)
  • hepatocellular carcinoma
  • recurrence
  • tenofovir disoproxil fumarate (T, chronic hepatitis B

Cite this